Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?

Journal of Surgical Research

Volumn 99, Issue 2, 2001, Pages 161-168

  Kymionis, G D ^a   Dimitrakakis, C E ^b   Konstadoulakis, M M ^a   Arzimanoglou, I ^c   Leandros, E ^a   Chalkiadakis, G ^d   Keramopoulos, A ^b   Michalas, S ^b  

^a HIPPOKRATION HOSPITAL   (Greece)

^b ALEXANDRA HOSPITAL   (Greece)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Apoptosis; Bax; bcl 2; Breast cancer; Chemotherapy; Node negative

Indexed keywords

CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PROGESTERONE RECEPTOR; PROTEIN BAX; PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; BREAST CARCINOMA; BREAST SURGERY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG RESPONSE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034901006     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2001.6084     Document Type: Article

References (40)

1. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: Analysis in more than 900 patients
2. Tenascin staining positivity and the survival of patients with invasive breast carcinoma
3. Apoptosis: Its significance in cancer and cancer therapy
4. Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis
5. Expression of the bcl-2 gene family in normal and malignant breast tissue: Low bax-a expression in tumor cells correlates with resistance towards apoptosis
6. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma
7. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation
8. bcl-2 gene transfer increases relative resistance of 549.1 and WEH 17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs
9. Reduced expression of proapoptotic gene bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma
10. Stereotactic core biopsy reduces the reexcision rate and the cost of mammographically detected cancer
11. Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients
12. Meta-analysis of sentinel lymph node biopsy in breast cancer
13. Oncogene protein coexpression: Value of Ha-ras, c-myc, c-fos, and p-53 as prognostic discriminants for breast carcinoma
14. Failure of programmed cell death and differentiation as causes of tumors: Some simple mathematical models
15. Regulation of apoptosis by bcl-2 and its related proteins: Immunochemical challenges and therapeutic implications
16. bcl-2 and the regulation of programmed cell death
17. Checkpoints of dueling dimers foil death wishes
18. bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death
19. Expression of bcl-2 protein in esophageal squamous cell carcinomas and its association with lymph node metastasis
20. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions
21. bcl-2 oncoprotein positivity and high MIB-1 (Ki-67) proliferative rate are independent predictive markers for recurrence in prostate carcinoma
22. Expression of bcl-2 in testicular carcinoma: Correlation with tumor progression and MDR1/Pgp
23. Immunohistochemical detection of p53 and bcl-2 in colorectal carcinoma: No evidence for prognostic significance
24. Bax expression has prognostic significance that is enhanced when combined with AgNOR counts in glottic carcinomas
25. Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancer
26. Apoptosis, cell proliferation and expression of bcl-2 and bax in gastric carcinomas: Immunohistochemical and clinicopathological study
27. bcl-2: Prevention of apoptosis as a mechanism of drug resistance
28. bcl-2 and apoptosis in lymph node positive breast carcinoma
29. bcl-2 protein expression and long-term survival in breast cancer
30. The bcl-2 protein: A prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients
31. bcl-2 slows in vitro breast cancer growth despite its antiapoptotic effect
32. Immunocytochemical localization of bcl-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy
33. Expression of bcl-2, but not bax, correlates with estrogen receptor status and tumor proliferation in invasive breast carcinoma
34. In vivo patterns of bcl-2 family protein expression in breast carcinomas in relation to apoptosis
35. Analysis of bax and bcl-2 expression in p53-immunopositive breast cancers
36. Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer
37. bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair
38. Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression
39. Expression of bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy
40. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy